QUINIDINE SULFATE INJECTION 190MG/ML DIN 00497525
Health Canada record
| Active ingredient(s) | QUINIDINE SULFATE 190 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | ETHICAL |
| Class | Human |
| ATC | C01BA01 QUINIDINE |
| Original market date | 31-Dec-1981 |
| Current status date | 10-Sep-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hospira Healthcare India Pvt. Ltd. — licence , not currently licensed, last inspection rating NC (2017-07-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing QUINIDINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00441740 | APO QUINIDINE TAB 200MG | APOTEX INC | Tablet | QUINIDINE SULFATE 200 MG | Cancelled Post Market |
| 00021733 | NOVO-QUINIDIN 200MG | NOVOPHARM LIMITED | Tablet | QUINIDINE SULFATE 200 MG | Cancelled Post Market |
| 02043505 | QUINIDEX EXTENTABS SRT 300MG | WYETH-AYERST CANADA INC. | Tablet (Extended-Release) | QUINIDINE SULFATE 300 MG | Cancelled Post Market |
| 01913883 | QUINIDEX EXTENTABS SRT 300MG | AYERST LABORATORIES | Tablet (Extended-Release) | QUINIDINE SULFATE 300 MG | Cancelled Post Market |
| 00563692 | QUINIDINE 200 TAB | PRO DOC LIMITEE | Tablet | QUINIDINE SULFATE 200 MG | Cancelled Post Market |
| 00026883 | QUINIDINE SULFATE 200MG | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | Tablet | QUINIDINE SULFATE 200 MG | Cancelled Post Market |
| 00004782 | QUINIDINE SULFATE TAB 200MG | GLAXO WELLCOME INC. | Tablet | QUINIDINE SULFATE 200 MG | Cancelled Post Market |
| 00179256 | QUINIDINE SULFATE TAB 200MG | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | Tablet | QUINIDINE SULFATE 195 MG | Cancelled Post Market |
International API supply for QUINIDINE SULFATE
1 valid EDQM Certificates of Suitability from 1 holders. 1 active FDA Drug Master Files.
Request a quote for QUINIDINE SULFATE INJECTION 190MG/ML